BioSpace News Archive

New Drug Laws, Higher Rates of Legal Marijuana and CBD Use Underscore Importance of Staying Up to Date

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that both batches of the company’s manufactured clinical trial product have undergone and passed all 10 of the necessary “release tests” required by the U.S. Food and Drug Administration (FDA).

J.H. Whitney Capital Partners, LLC, a leading private equity investment firm, is pleased to announce the sale of its portfolio company Accupac, Inc. to Palladium Equity Partners..

The U.S. Centers for Disease Control and Prevention confirmed the first U.S. case of a mysterious coronavirus that has already killed several people and sickened hundreds of others in China.

Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya” or the “Company”), has signed a $151.5 million USD international marketing partnership agreement with Regenerative Medicine of Latin America, Inc. for the exclusive rights to market and sell all biological drugs developed by Zhittya during a 30-year time period.

US kidney dialysis center revenues are forecast to advance 4.9% annually in nominal dollars through 2023, according to Kidney Dialysis Centers: United States, a report recently released by Freedonia Focus Reports.

Neurotrope, Inc. (the “Company”) (NASDAQ:NTRP) today announced that it has received commitments from institutional investors and pre-existing high net worth individuals to purchase an aggregate of $18 million of the Company’s securities in a registered direct offering.

4basebio AG (Frankfurt: 4BSB; ISIN: DE000A2YN801; Prime Standard) today announced that the Company has completed the name change from Expedeon AG to 4basebio AG

Finalists to Compete for More Than $1.8 Million in Oldest and Most Prestigious U.S. STEM Competition for High School Seniors

CrossBay Medical, Inc., a health technology company focused on humanizing the delivery of women’s healthcare, has announced the launch of a new website, introducing its CrossGlide™ technology platform.